Results 201 to 210 of about 700,727 (353)
Modernising antiviral drug discovery: harnessing medicinal plants through machine learning and metabolomics to target the SARS-CoV-2 main protease. [PDF]
Msobo A +4 more
europepmc +1 more source
In silico modelling of transporter-mediated xenobiotic flux through cells
Samantha L. Forster
openalex +1 more source
The FAK‐STAT3‐NNMT axis drives anoikis resistance in circulating tumor cells by reprogramming fatty acid oxidation. Targeting this metabolic vulnerability suppresses metastasis, untangling a key mechanism of breast cancer progression and revealing NNMT as a promising therapeutic target.
Qingchao Tong +13 more
wiley +1 more source
Measurable Feature Prediction for Estimating Chemical Space Coverage in LC-ESI-HRMS Nontargeted Analysis. [PDF]
Renai L +4 more
europepmc +1 more source
A Holistic In Silico Approach to Find Novel Inhibitors for Erbb1 and Erbb2 Kinases
Jian Bin Hu, Ming Jun Dong
openalex +1 more source
In silico Study of Pyrano [2,3-C] Pyrazoles Derivatives as Selective Serotonin Reuptake Inhibitiors
Bais Abhinav
openalex +1 more source
A semiconductor‐fabricated nanowell biosensor enables rapid, scalable, and highly reproducible detection of SARS‐CoV‐2 antigens from nasal swabs within ∼10 minutes. Clinical validation in 249 retrospective and 243 prospective patient samples demonstrates high sensitivity and specificity, minimal cross‐reactivity, and robust batch‐to‐batch ...
Yoo Min Park +11 more
wiley +1 more source
Interpreting circulating microbiome-related metabolites in coronary heart disease. [PDF]
Sun Z, Shi M, Zheng Y.
europepmc +1 more source
In Silico T Cell Epitope Identification for SARS-CoV-2: Progress and Perspectives
Muhammad Saqib Sohail +3 more
openalex +1 more source

